Drug pricing

Sandoz board chair ‘convinced that common sense will ultimately prevail’ on US pharma tariffs

This content was published on Jun 28, 2025 In an exclusive interview with Swissinfo, Sandoz chair Gilbert Ghostine says he remains optimistic despite looming tariff hikes.

A young patient is fitted with an exoskeleton.

Medicine access

Rare diseases take centre stage at global health summit

This content was published on May 27, 2025 Rare diseases have been recognised as a global health priority for the first time. How could this impact access to life-saving treatment?

Medicine access

Despite Trump’s bold claims, medicine prices in Europe won’t rise anytime soon

This content was published on May 15, 2025 US President Trump has taken aim at Europe for undercharging for medicine. But raising prices in Europe would face strong pushback.

Medicine access

Trump’s promise to lower drug prices rattles Swiss pharma stocks

This content was published on May 12, 2025 US President Trump wants to make medicines cheaper in the US, which could mean huge losses for drugmakers, including those in Switzerland.

There are thousands of videos about weight-loss drugs on social media that can be seen from anywhere in the world.

Medicine access

Swiss regulator and media clash over weight-loss drugs

This content was published on Jan 21, 2025 Swissmedic has taken legal action against media for alleged unauthorised advertising of weight-loss drugs. Swiss media say this is censorship.

Medicine access

Whatever happened to the world’s most expensive drug?

This content was published on Apr 23, 2024 Swiss pharma giant Novartis launched Zolgensma five years ago with a price tag of $2.1 million. What happened to it?

How drug prices are negotiated in Switzerland and beyond

This content was published on Apr 23, 2024 Switzerland's pharmaceutical sector supplies drugs worldwide, but not all countries receive them with the same price tag. Here's why.

Drug pricing

Popular Stories

Most Discussed

Drug pricing

More

Sandoz board chair ‘convinced that common sense will ultimately prevail’ on US pharma tariffs

More

Rare diseases take centre stage at global health summit

More

Despite Trump’s bold claims, medicine prices in Europe won’t rise anytime soon

More

Trump’s promise to lower drug prices rattles Swiss pharma stocks

More

Swiss regulator and media clash over weight-loss drugs

More

Whatever happened to the world’s most expensive drug?

More

How drug prices are negotiated in Switzerland and beyond

Popular Stories

Most Discussed